
Keywords: AMD; age-related macular degeneration; ATP; adenosine triphosphate; A1R; adenosine receptor type A1; A2AR; adenosine receptor type A2A; A2BR; adenosine receptor type A2B; A3R; adenosine receptor type A3; BDNF; brain-derived neurotrophic factor; CI; contin